Vol. 26 No. 4 (2021): Vol. 25 No. 4 (2021)

Published: 2021-12-23

Editorial

A Note From the Editor in Chief

Arthur A Boni
- Requires Subscription or Fee PDF (USD 25)

Articles

Drug Repositioning as a Pharmaceutical Strategy: The Obvious Benefits are Real but Beware of Pitfalls That May be Less Apparent.

Andrew G. Reaume
- Requires Subscription or Fee PDF (USD 25)
Strategic Alliance and Acquisition Performance: Impact of Interfirm Synergies and Motives in the Bio-Pharmaceutical Industry

Thani Jambulingam, Todd Saxton
- Requires Subscription or Fee PDF (USD 25)
Australian Biotechnology: A 10-Year Study of Investor Performance

Peter L. Molloy , Lester W. Johnson, Michael Gilding
- Requires Subscription or Fee PDF (USD 25)
The Role of the Biotechnology Industry in Addressing Health Inequities in Africa: Strengthening the Entire Health Care Value Chain

Stephen M. Sammut
- Requires Subscription or Fee PDF (USD 25)
Considerations for Potential Global Expansion of Serum Institute of India

Veena Somasundaram, Peter Soukas, Jenish Patel, Steven Ferguson
- Requires Subscription or Fee PDF (USD 25)

From the Boardroom

A conversation on accelerating innovation in biopharma and life sciences through global collaboration and alliances

Arthur A Boni, Peter L. Molloy
- Requires Subscription or Fee PDF (USD 25)